| GO:0010343 | singlet oxygen-mediated programmed cell death | 2.22% (3/135) | 9.0 | 0.0 | 6e-06 |
| GO:0000304 | response to singlet oxygen | 2.22% (3/135) | 9.0 | 0.0 | 6e-06 |
| GO:0097468 | programmed cell death in response to reactive oxygen species | 2.22% (3/135) | 9.0 | 0.0 | 6e-06 |
| GO:0003723 | RNA binding | 11.11% (15/135) | 2.33 | 0.0 | 5.4e-05 |
| GO:0003729 | mRNA binding | 5.93% (8/135) | 3.4 | 1e-06 | 0.000119 |
| GO:0140513 | nuclear protein-containing complex | 8.89% (12/135) | 2.58 | 1e-06 | 0.000124 |
| GO:0005575 | cellular_component | 37.04% (50/135) | 0.89 | 3e-06 | 0.00023 |
| GO:0034976 | response to endoplasmic reticulum stress | 3.7% (5/135) | 4.53 | 3e-06 | 0.000235 |
| GO:1990904 | ribonucleoprotein complex | 6.67% (9/135) | 2.96 | 3e-06 | 0.000259 |
| GO:0012501 | programmed cell death | 2.22% (3/135) | 6.57 | 5e-06 | 0.000273 |
| GO:0008219 | cell death | 2.22% (3/135) | 6.57 | 5e-06 | 0.000273 |
| GO:0008150 | biological_process | 45.93% (62/135) | 0.72 | 6e-06 | 0.00028 |
| GO:0016592 | mediator complex | 2.96% (4/135) | 5.09 | 7e-06 | 0.000315 |
| GO:0032991 | protein-containing complex | 14.07% (19/135) | 1.6 | 1.6e-05 | 0.000703 |
| GO:0005681 | spliceosomal complex | 3.7% (5/135) | 3.89 | 2.6e-05 | 0.00105 |
| GO:0000302 | response to reactive oxygen species | 2.22% (3/135) | 5.7 | 3e-05 | 0.001126 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 5.19% (7/135) | 2.97 | 3.7e-05 | 0.00132 |
| GO:0009987 | cellular process | 32.59% (44/135) | 0.82 | 5.7e-05 | 0.001928 |
| GO:0065007 | biological regulation | 14.81% (20/135) | 1.38 | 8.3e-05 | 0.002633 |
| GO:0005488 | binding | 37.04% (50/135) | 0.71 | 0.000101 | 0.003074 |
| GO:0050794 | regulation of cellular process | 13.33% (18/135) | 1.4 | 0.000161 | 0.004651 |
| GO:0009862 | systemic acquired resistance, salicylic acid mediated signaling pathway | 1.48% (2/135) | 6.64 | 0.000194 | 0.005103 |
| GO:0009863 | salicylic acid mediated signaling pathway | 1.48% (2/135) | 6.64 | 0.000194 | 0.005103 |
| GO:0005684 | U2-type spliceosomal complex | 2.22% (3/135) | 4.74 | 0.000213 | 0.005159 |
| GO:0003676 | nucleic acid binding | 15.56% (21/135) | 1.24 | 0.000206 | 0.005192 |
| GO:0000245 | spliceosomal complex assembly | 1.48% (2/135) | 6.46 | 0.000249 | 0.005596 |
| GO:0003674 | molecular_function | 50.37% (68/135) | 0.51 | 0.000245 | 0.005712 |
| GO:0070847 | core mediator complex | 1.48% (2/135) | 6.42 | 0.000264 | 0.00572 |
| GO:0050789 | regulation of biological process | 13.33% (18/135) | 1.33 | 0.000293 | 0.00612 |
| GO:0140110 | transcription regulator activity | 6.67% (9/135) | 2.06 | 0.000352 | 0.007103 |
| GO:0003712 | transcription coregulator activity | 2.96% (4/135) | 3.6 | 0.000364 | 0.007115 |
| GO:0010035 | response to inorganic substance | 2.22% (3/135) | 4.41 | 0.000413 | 0.00782 |
| GO:0051252 | regulation of RNA metabolic process | 8.15% (11/135) | 1.73 | 0.000536 | 0.009845 |
| GO:0030134 | COPII-coated ER to Golgi transport vesicle | 1.48% (2/135) | 5.83 | 0.0006 | 0.010093 |
| GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 1.48% (2/135) | 5.76 | 0.000654 | 0.010159 |
| GO:0042221 | response to chemical | 3.7% (5/135) | 2.92 | 0.000573 | 0.010216 |
| GO:0080090 | regulation of primary metabolic process | 8.89% (12/135) | 1.61 | 0.000642 | 0.010238 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 8.89% (12/135) | 1.62 | 0.000591 | 0.010239 |
| GO:0097159 | organic cyclic compound binding | 25.19% (34/135) | 0.81 | 0.000633 | 0.010371 |
| GO:0060255 | regulation of macromolecule metabolic process | 9.63% (13/135) | 1.5 | 0.000745 | 0.011005 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 8.15% (11/135) | 1.67 | 0.00074 | 0.01121 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 5.19% (7/135) | 2.23 | 0.000805 | 0.011341 |
| GO:0031323 | regulation of cellular metabolic process | 9.63% (13/135) | 1.49 | 0.000787 | 0.011352 |
| GO:2000022 | regulation of jasmonic acid mediated signaling pathway | 1.48% (2/135) | 5.57 | 0.000848 | 0.011676 |
| GO:2000031 | regulation of salicylic acid mediated signaling pathway | 1.48% (2/135) | 5.52 | 0.000912 | 0.012277 |
| GO:0019222 | regulation of metabolic process | 9.63% (13/135) | 1.45 | 0.001047 | 0.013505 |
| GO:0010468 | regulation of gene expression | 8.89% (12/135) | 1.53 | 0.001026 | 0.013519 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 8.89% (12/135) | 1.52 | 0.001087 | 0.013723 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 5.19% (7/135) | 2.1 | 0.001379 | 0.01466 |
| GO:0016462 | pyrophosphatase activity | 5.19% (7/135) | 2.14 | 0.001186 | 0.014664 |
| GO:0033554 | cellular response to stress | 5.19% (7/135) | 2.1 | 0.001365 | 0.014772 |
| GO:0000469 | obsolete cleavage involved in rRNA processing | 0.74% (1/135) | 9.54 | 0.001347 | 0.014843 |
| GO:0006895 | Golgi to endosome transport | 0.74% (1/135) | 9.54 | 0.001347 | 0.014843 |
| GO:0009889 | regulation of biosynthetic process | 8.89% (12/135) | 1.49 | 0.00127 | 0.015095 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.19% (7/135) | 2.11 | 0.001306 | 0.015226 |
| GO:0031326 | regulation of cellular biosynthetic process | 8.89% (12/135) | 1.49 | 0.001263 | 0.015302 |
| GO:1901700 | response to oxygen-containing compound | 2.22% (3/135) | 3.82 | 0.00134 | 0.015322 |
| GO:0042651 | thylakoid membrane | 2.22% (3/135) | 3.72 | 0.001614 | 0.0163 |
| GO:0034357 | photosynthetic membrane | 2.22% (3/135) | 3.72 | 0.001614 | 0.0163 |
| GO:0051716 | cellular response to stimulus | 5.19% (7/135) | 2.06 | 0.001609 | 0.016814 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 2.96% (4/135) | 2.95 | 0.001927 | 0.018536 |
| GO:0009891 | positive regulation of biosynthetic process | 2.96% (4/135) | 2.95 | 0.001927 | 0.018536 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 2.96% (4/135) | 2.95 | 0.001927 | 0.018536 |
| GO:0030173 | obsolete integral component of Golgi membrane | 1.48% (2/135) | 4.93 | 0.002053 | 0.018851 |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 2.22% (3/135) | 3.61 | 0.002023 | 0.018861 |
| GO:0034513 | box H/ACA snoRNA binding | 0.74% (1/135) | 8.95 | 0.00202 | 0.019127 |
| GO:0140326 | ATPase-coupled intramembrane lipid transporter activity | 1.48% (2/135) | 4.85 | 0.002278 | 0.020608 |
| GO:0007030 | Golgi organization | 1.48% (2/135) | 4.83 | 0.002337 | 0.020823 |
| GO:0030135 | coated vesicle | 1.48% (2/135) | 4.78 | 0.002485 | 0.021209 |
| GO:0045332 | phospholipid translocation | 1.48% (2/135) | 4.79 | 0.002455 | 0.021252 |
| GO:0140303 | intramembrane lipid transporter activity | 1.48% (2/135) | 4.8 | 0.002425 | 0.021298 |
| GO:0008117 | sphinganine-1-phosphate aldolase activity | 0.74% (1/135) | 8.54 | 0.002693 | 0.022662 |
| GO:0034204 | lipid translocation | 1.48% (2/135) | 4.7 | 0.002779 | 0.023066 |
| GO:0000470 | maturation of LSU-rRNA | 1.48% (2/135) | 4.64 | 0.003021 | 0.024742 |
| GO:0097035 | regulation of membrane lipid distribution | 1.48% (2/135) | 4.62 | 0.003104 | 0.025084 |
| GO:0110165 | cellular anatomical entity | 27.41% (37/135) | 0.63 | 0.003318 | 0.026114 |
| GO:0047958 | glycine:2-oxoglutarate aminotransferase activity | 0.74% (1/135) | 8.21 | 0.003365 | 0.02614 |
| GO:0016043 | cellular component organization | 7.41% (10/135) | 1.49 | 0.003295 | 0.026276 |
| GO:0015914 | phospholipid transport | 1.48% (2/135) | 4.54 | 0.003447 | 0.026444 |
| GO:0006950 | response to stress | 8.89% (12/135) | 1.31 | 0.003549 | 0.026887 |
| GO:0031325 | positive regulation of cellular metabolic process | 2.96% (4/135) | 2.64 | 0.004156 | 0.031089 |
| GO:0009853 | photorespiration | 0.74% (1/135) | 7.87 | 0.00426 | 0.031481 |
| GO:0031120 | snRNA pseudouridine synthesis | 0.74% (1/135) | 7.8 | 0.004484 | 0.032735 |
| GO:2001141 | regulation of RNA biosynthetic process | 6.67% (9/135) | 1.51 | 0.004631 | 0.033018 |
| GO:0006355 | regulation of DNA-templated transcription | 6.67% (9/135) | 1.51 | 0.004631 | 0.033018 |
| GO:0010236 | plastoquinone biosynthetic process | 0.74% (1/135) | 7.73 | 0.004707 | 0.033169 |
| GO:0031468 | nuclear membrane reassembly | 0.74% (1/135) | 7.66 | 0.004931 | 0.033201 |
| GO:0051743 | red chlorophyll catabolite reductase activity | 0.74% (1/135) | 7.66 | 0.004931 | 0.033201 |
| GO:0008883 | glutamyl-tRNA reductase activity | 0.74% (1/135) | 7.66 | 0.004931 | 0.033201 |
| GO:0006979 | response to oxidative stress | 2.22% (3/135) | 3.14 | 0.004999 | 0.033289 |
| GO:0031429 | box H/ACA snoRNP complex | 0.74% (1/135) | 7.6 | 0.005154 | 0.033586 |
| GO:0072588 | box H/ACA RNP complex | 0.74% (1/135) | 7.6 | 0.005154 | 0.033586 |
| GO:0034067 | protein localization to Golgi apparatus | 0.74% (1/135) | 7.54 | 0.005378 | 0.033948 |
| GO:0051230 | spindle disassembly | 0.74% (1/135) | 7.54 | 0.005378 | 0.033948 |
| GO:0051228 | mitotic spindle disassembly | 0.74% (1/135) | 7.54 | 0.005378 | 0.033948 |
| GO:0022607 | cellular component assembly | 3.7% (5/135) | 2.2 | 0.004926 | 0.03431 |
| GO:0097352 | autophagosome maturation | 0.74% (1/135) | 7.48 | 0.005601 | 0.034994 |
| GO:0006396 | RNA processing | 4.44% (6/135) | 1.88 | 0.00613 | 0.037906 |
| GO:0071709 | membrane assembly | 0.74% (1/135) | 7.31 | 0.006271 | 0.038388 |
| GO:0048522 | positive regulation of cellular process | 2.96% (4/135) | 2.46 | 0.006357 | 0.038522 |
| GO:0043226 | organelle | 14.81% (20/135) | 0.86 | 0.006759 | 0.038643 |
| GO:0071013 | catalytic step 2 spliceosome | 1.48% (2/135) | 4.08 | 0.006451 | 0.038708 |
| GO:0061024 | membrane organization | 2.22% (3/135) | 2.96 | 0.007068 | 0.038939 |
| GO:0043229 | intracellular organelle | 14.81% (20/135) | 0.86 | 0.006752 | 0.038969 |
| GO:0071012 | catalytic step 1 spliceosome | 0.74% (1/135) | 7.21 | 0.006718 | 0.039144 |
| GO:0071006 | U2-type catalytic step 1 spliceosome | 0.74% (1/135) | 7.21 | 0.006718 | 0.039144 |
| GO:0009893 | positive regulation of metabolic process | 2.96% (4/135) | 2.42 | 0.007044 | 0.039163 |
| GO:0030970 | retrograde protein transport, ER to cytosol | 0.74% (1/135) | 7.08 | 0.007387 | 0.039268 |
| GO:1903513 | endoplasmic reticulum to cytosol transport | 0.74% (1/135) | 7.08 | 0.007387 | 0.039268 |
| GO:0017070 | U6 snRNA binding | 0.74% (1/135) | 7.08 | 0.007387 | 0.039268 |
| GO:0033013 | tetrapyrrole metabolic process | 1.48% (2/135) | 3.99 | 0.007199 | 0.039304 |
| GO:0071840 | cellular component organization or biogenesis | 7.41% (10/135) | 1.33 | 0.006959 | 0.039413 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 2.96% (4/135) | 2.42 | 0.00703 | 0.039444 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 2.96% (4/135) | 2.44 | 0.006716 | 0.039899 |
| GO:0032527 | protein exit from endoplasmic reticulum | 0.74% (1/135) | 7.03 | 0.00761 | 0.040102 |
| GO:0051788 | response to misfolded protein | 0.74% (1/135) | 6.76 | 0.00917 | 0.044813 |
| GO:0061951 | establishment of protein localization to plasma membrane | 0.74% (1/135) | 6.76 | 0.00917 | 0.044813 |
| GO:0043001 | Golgi to plasma membrane protein transport | 0.74% (1/135) | 6.76 | 0.00917 | 0.044813 |
| GO:0071218 | cellular response to misfolded protein | 0.74% (1/135) | 6.76 | 0.00917 | 0.044813 |
| GO:0035966 | response to topologically incorrect protein | 0.74% (1/135) | 6.69 | 0.009615 | 0.045521 |
| GO:0035967 | cellular response to topologically incorrect protein | 0.74% (1/135) | 6.69 | 0.009615 | 0.045521 |
| GO:0015748 | organophosphate ester transport | 1.48% (2/135) | 3.85 | 0.008725 | 0.045581 |
| GO:0045893 | positive regulation of DNA-templated transcription | 2.22% (3/135) | 2.83 | 0.009076 | 0.045833 |
| GO:1902680 | positive regulation of RNA biosynthetic process | 2.22% (3/135) | 2.83 | 0.009076 | 0.045833 |
| GO:0046907 | intracellular transport | 3.7% (5/135) | 1.99 | 0.008885 | 0.046018 |
| GO:0022625 | cytosolic large ribosomal subunit | 1.48% (2/135) | 3.78 | 0.00958 | 0.046074 |
| GO:0050896 | response to stimulus | 8.89% (12/135) | 1.13 | 0.008979 | 0.046114 |
| GO:0048193 | Golgi vesicle transport | 2.22% (3/135) | 2.8 | 0.009564 | 0.046366 |
| GO:0051649 | establishment of localization in cell | 3.7% (5/135) | 1.95 | 0.010179 | 0.047816 |
| GO:0000338 | protein deneddylation | 0.74% (1/135) | 6.6 | 0.010282 | 0.047931 |
| GO:0006430 | lysyl-tRNA aminoacylation | 0.74% (1/135) | 6.57 | 0.010505 | 0.048226 |
| GO:0004824 | lysine-tRNA ligase activity | 0.74% (1/135) | 6.57 | 0.010505 | 0.048226 |
| GO:0035101 | FACT complex | 0.74% (1/135) | 6.54 | 0.010727 | 0.048511 |
| GO:0040031 | snRNA modification | 0.74% (1/135) | 6.54 | 0.010727 | 0.048511 |
